|Awarded On||August 18, 2021|
|Title||Building a Clinical Trial Network for Texas Community Affiliates|
|Award Mechanism||Clinical Trials Network Award|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Michael Overman|
|Cancer Sites||All Sites|
The University of Texas MD Anderson Cancer Center will serve as the lead institution for a clinical-trials network (CTN) that will offer new cancer treatments (clinical trials) to minority patients at two new sites. Those sites are Lyndon B. Johnson (LBJ) Hospital of Harris County, Texas, and the University of Texas Medical Branch (UTMB) in Galveston County, Texas. LBJ, is a public hospital that sees a high number of minorities (53.6% Hispanic, 25.3% Black/African American). About 54% of those patients are uninsured. UTMB, provides health care for low-income and medically underserved people in Galveston County. Their patient group is 26% minority and 15.5% uninsured. Leaders from all 3 sites...